Randomized, Double Blind, Placebo-controlled Topical Resiquimod Adjuvant for NY-ESO-1 Protein Vaccination

Clinical Trial ID NCT00821652

PubWeight™ 8.14^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00821652

Top papers